01 1Calyx Chemicals & Pharmaceuticals
01 1ERYTHROMYCIN
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2016-11-10
Pay. Date : 2016-09-27
DMF Number : 20137
Submission : 2006-12-14
Status : Active
Type : II
20
Calyx Chemicals And Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and WHO-GMP.
One of their notable products is ERYTHROMYCIN, with a corresponding US DMF Number 20137.
Remarkably, this DMF maintains an Active status since its submission on December 14, 2006, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 10, 2016, and payment made on September 27, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II
